Buy CVS stocks now with Interactive Brokers – the most advanced investment platform
- Performance
- Key stats
- Financials
- US politician trades
CVS stock trades by the US Senators and Representatives
In the last 12 months Finbold has discovered a total of 2 CVS trades made by 2 politicians. The the same period there was a total of 0 buy trades , and 2 sell trades amounting to $2K - $30K . Based on this information, it appears that none of the total politicians preferred to buy CVS HEALTH CORPORATION stock, while 100.00% of the politicians preferred to sell CVS HEALTH CORPORATION stock.
The largest recorded CVS stock trade by the US politician in the last 12 months was made by , with a disclosed amount of between .
CVS stock does not seem to have any one politician who would have done more than one CVS HEALTH CORPORATION stock trade in the last 12 months.
Percentage
November 2024
Senator | Action | Amount | Date | Owner | Type |
---|---|---|---|---|---|
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Unlock 1 Latest Transaction
Upgrade now to access all U.S. politician trades for this and other stocks. Get the latest signals as they come.
July 2024
Name | Action | Traded at | Amount | |
---|---|---|---|---|
Earl BlumenauerCongressman |
Sale |
June 27
July 6
|
$1K - $15K |
Signal Details
Earl BlumenauerCongressman
Action
Sale
Traded at
June 27
Disclosed at
July 6
Amount
1K - $15K
Owner
Spouse
|
Methodology:
For trading activity of US Members of Congress, we collect data from the Financial Disclosures website. For US Senate trading activity, the data is collected from the United States Senate Financial Disclosures (eFD) website.
The price change since the date of disclosure is calculated by comparing the stock's closing price on the date of the disclosure to the current price of the asset.